Literature DB >> 31768392

Nutritional Intervention in Chronic Liver Failure.

Mathias Plauth1.   

Abstract

Patients suffering from chronic liver failure (CLF) frequently are malnourished and do not achieve an adequate intake of nutrients, in particular protein. Low protein intake and loss of muscle mass and function, termed sarcopenia, are indicators of a poor outcome. CLF patients, therefore, should be screened for risk of malnutrition using a validated tool, and if positive, full assessment of nutritional status is mandatory including search for sarcopenia. The main goal of nutritional intervention is to provide enough protein (1.2-1.5 g × kg<sup>-1</sup> × day<sup>-1</sup>) and to ensure adequate energy intake (total energy 30 kcal × kg<sup>-1</sup> × day<sup>-1</sup>; 1.3 × resting energy expenditure). Livers of CLF patients are deplete in glycogen and, therefore, prolonged periods of fasting (>12 h) must be avoided in order to prevent further breakdown of muscle protein for gluconeogenesis. Therefore, late evening snacks or even nocturnal oral nutritional supplements improve total body -protein status and thus, are recommended. Nutrition intervention should be stepped up from nutrition counselling to oral nutritional supplements, to enteral tube feeding, or to parenteral nutrition as appropriate. As in other malnourished patients, the prevention of refeeding syndrome or vitamin/trace element deficiency should be taken care of.
Copyright © 2019 by S. Karger AG, Basel.

Entities:  

Keywords:  Chronic liver failure; Malnutrition; Nutritional intervention; Sarcopenia

Year:  2019        PMID: 31768392      PMCID: PMC6873018          DOI: 10.1159/000502125

Source DB:  PubMed          Journal:  Visc Med        ISSN: 2297-4725


  47 in total

1.  Pre- and postoperative immunonutrition in patients undergoing liver transplantation: a pilot study of safety and efficacy.

Authors:  Lindsay D Plank; John L McCall; Edward J Gane; Mohammad Rafique; Lynn K Gillanders; Kerry McIlroy; Stephen R Munn
Journal:  Clin Nutr       Date:  2005-04       Impact factor: 7.324

Review 2.  Energy and protein requirements of patients with chronic liver disease.

Authors:  J Kondrup; M J Müller
Journal:  J Hepatol       Date:  1997-07       Impact factor: 25.083

3.  Sarcopenia and mortality after liver transplantation.

Authors:  Michael J Englesbe; Shaun P Patel; Kevin He; Raymond J Lynch; Douglas E Schaubel; Calista Harbaugh; Sven A Holcombe; Stewart C Wang; Dorry L Segev; Christopher J Sonnenday
Journal:  J Am Coll Surg       Date:  2010-06-26       Impact factor: 6.113

4.  Functional decline in patients with cirrhosis awaiting liver transplantation: Results from the functional assessment in liver transplantation (FrAILT) study.

Authors:  Jennifer C Lai; Jennifer L Dodge; Saunak Sen; Kenneth Covinsky; Sandy Feng
Journal:  Hepatology       Date:  2015-12-16       Impact factor: 17.425

5.  Obesity is an independent risk factor for clinical decompensation in patients with cirrhosis.

Authors:  Annalisa Berzigotti; Guadalupe Garcia-Tsao; Jaime Bosch; Norman D Grace; Andrew K Burroughs; Rosa Morillas; Angels Escorsell; Juan Carlos Garcia-Pagan; David Patch; Daniel S Matloff; Roberto J Groszmann
Journal:  Hepatology       Date:  2011-06-26       Impact factor: 17.425

6.  The gap between clinically assessed physical performance and objective physical activity in liver transplant candidates.

Authors:  Michael A Dunn; Deborah A Josbeno; Amy R Schmotzer; Amit D Tevar; Andrea F DiMartini; Douglas P Landsittel; Anthony Delitto
Journal:  Liver Transpl       Date:  2016-10       Impact factor: 5.799

7.  Effects of an intensive lifestyle intervention program on portal hypertension in patients with cirrhosis and obesity: The SportDiet study.

Authors:  Annalisa Berzigotti; Agustín Albillos; Candid Villanueva; Joan Genescá; Alba Ardevol; Salvador Augustín; Jose Luis Calleja; Rafael Bañares; Juan Carlos García-Pagán; Francisco Mesonero; Jaime Bosch
Journal:  Hepatology       Date:  2017-03-06       Impact factor: 17.425

8.  Isoleucine infusion during "simulated" upper gastrointestinal bleeding improves liver and muscle protein synthesis in cirrhotic patients.

Authors:  Steven W M Olde Damink; Rajiv Jalan; Nicolaas E P Deutz; Cornelis H C Dejong; Doris N Redhead; Paula Hynd; Peter C Hayes; Peter B Soeters
Journal:  Hepatology       Date:  2007-03       Impact factor: 17.425

9.  Nutritional status in cirrhosis. Italian Multicentre Cooperative Project on Nutrition in Liver Cirrhosis.

Authors: 
Journal:  J Hepatol       Date:  1994-09       Impact factor: 25.083

10.  Nutritional supplementation with branched-chain amino acids in advanced cirrhosis: a double-blind, randomized trial.

Authors:  Giulio Marchesini; Giampaolo Bianchi; Manuela Merli; Piero Amodio; Carmine Panella; Carmela Loguercio; Fillipo Rossi Fanelli; Roberto Abbiati
Journal:  Gastroenterology       Date:  2003-06       Impact factor: 22.682

View more
  1 in total

1.  Serum Zinc Level and non-Protein Respiratory Quotient in Patients with Chronic Liver Diseases.

Authors:  Hiroki Nishikawa; Ryo Takata; Hirayuki Enomoto; Kazunori Yoh; Yoshinori Iwata; Yoshiyuki Sakai; Kyohei Kishino; Yoshihiro Shimono; Naoto Ikeda; Tomoyuki Takashima; Nobuhiro Aizawa; Kunihiro Hasegawa; Noriko Ishii; Yukihisa Yuri; Takashi Nishimura; Hiroko Iijima; Shuhei Nishiguchi
Journal:  J Clin Med       Date:  2020-01-17       Impact factor: 4.241

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.